PhRMA Wants Clearer Definition Of Safety “Signal”; FDA Proposes Newsletter
Executive Summary
FDA's upcoming pharmacovigilance guidance should include a clearer definition of what constitutes a drug risk "signal," the Pharmaceutical Research & Manufacturers of America maintains
You may also be interested in...
FDA Adverse Event Data Mining Systems To Be Created By Lincoln Technologies
FDA's agreement with Boston-based Lincoln Technologies to create adverse event data mining technology is the second cooperative research and development agreement between the two
FDA Adverse Event Data Mining Systems To Be Created By Lincoln Technologies
FDA's agreement with Boston-based Lincoln Technologies to create adverse event data mining technology is the second cooperative research and development agreement between the two
PhRMA-FDA Working Group To Develop Best Practices For Data Mining
A Pharmaceutical Research & Manufacturers of America-FDA working group is looking at developing "best practices" for data mining techniques to identify potential safety signals